About
Pgdx develops a molecular diagnostic platform that utilizes CRISPR and synthetic biology technologies to enable point-of-care diagnostics.
Explore Pgdx's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.